The U.S. FDA granted San Diego-based Evofem Biosciences Fast Track designation for Amphora vaginal gel to prevent urogenital chlamydia infection in women.
New data from Novartis’ breast cancer drug Kisqali underscored its effectiveness in pre-menopausal women, the Swiss drugmaker said, amid efforts to muscle in on turf dominated by rival Pfizer’s Ibrance.
AstraZeneca has entered into an agreement with Sandoz, the generic pharmaceuticals division of Novartis, to resolve Faslodex patent litigation in the U.S.
Postmenopausal women who are given an activity level goal for the week end up getting more activity when using a Fitbit than a traditional pedometer, according to a new study. The Fitbit devices are small activity trackers that can be attached to clothing or worn on the wrist like a watch. They collect activity data, […]